Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2025)

Eton Pharmaceuticals' Other Non-Current Assets history spans 8 years, with the latest figure at $19000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 58.33% to $19000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $19000.0, a 58.33% increase, with the full-year FY2025 number at $19000.0, up 58.33% from a year prior.
  • Other Non-Current Assets hit $19000.0 in Q4 2025 for Eton Pharmaceuticals, roughly flat from $19000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ETON hit a ceiling of $36000.0 in Q1 2021 and a floor of $12000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $15900.0 across 5 years, with a median of $12000.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: crashed 71.6% in 2021 and later surged 58.33% in 2025.
  • Tracing ETON's Other Non-Current Assets over 5 years: stood at $21000.0 in 2021, then crashed by 42.86% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then surged by 58.33% to $19000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for ETON at $19000.0 in Q4 2025, $19000.0 in Q3 2025, and $12000.0 in Q2 2025.